Cited by 1,017

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

MAST CELLS AS “TUNABLE” EFFECTOR AND IMMUNOREGULATORY CELLS: Recent Advances

Galli, Stephen J., Kalesnikoff, Janet, Grimbaldeston, Michele A., Piliponsky, Adrian M., Williams, Cara M.M., Tsai, Mindy·2005·Annual Review of Immunology

DOI 10.1146/annurev.immunol.21.120601.141025

Open this paper in CoChat — free account

Abstract

▪ Abstract This review focuses on recent progress in our understanding of how mast cells can contribute to the initiation, development, expression, and regulation of acquired immune responses, both those associated with IgE and those that are apparently expressed independently of this class of Ig. We emphasize findings derived from in vivo studies in mice, particularly those employing genetic approaches to influence mast cell numbers and/or to alter or delete components of pathways that can regulate mast cell development, signaling, or function. We advance the hypothesis that mast cells not only can function as proinflammatory effector cells and drivers of tissue remodeling in established acquired immune responses, but also may contribute to the initiation and regulation of such responses. That is, we propose that mast cells can also function as immunoregulatory cells. Finally, we show that the notion that mast cells have primarily two functional configurations, off (or resting) or on (or activated for extensive mediator release), markedly oversimplifies reality. Instead, we propose that mast cells are “tunable,” by both genetic and environmental factors, such that, depending on the circumstances, the cell can be positioned phenotypically to express a wide spectrum of variation in the types, kinetics, and/or magnitude of its secretory functions.

Integrity signals

Registry

Crossref · 10.1146/annurev.immunol.21.120601.141025

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

THE HIGH-AFFINITY I g E RECEPTOR (FcεRI): From Physiology to Pathology
Kinet, J.-P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.931 · Cited by 968
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development · doi:10.1101/gad.13.11.1382 · Cited by 946
Signal Transduction by the High-Affinity Immunoglobulin E Receptor FcεRI: Coupling Form to Function
Nadler, M. J. S., Matthews, S. A., Turner, H., & Kinet, J.-P. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)76022-1 · Cited by 203

Show all 3 references

Research works printed but not linked: 202

10.1146/annurev.iy.07.040189.000423 · DOI
10.1152/physrev.1997.77.4.1033 · DOI
Galli SJ, 1999, Fundamental Immunology, 1137
10.1016/S0065-2776(08)60508-8 · DOI
Galli SJ, 2005, Williams Hematology
10.1097/00062752-200001000-00007 · DOI
10.1067/mai.2000.106485 · DOI
10.1186/1471-2172-3-5 · DOI
10.1182/blood-2002-02-0602 · DOI
10.1182/blood-2002-12-3929 · DOI
10.1016/S1074-7613(04)00026-3 · DOI
10.1007/BF00232005 · DOI
10.1159/000233766 · DOI
Galli SJ, 1990, Lab. Invest., 62, 5
10.1023/A:1020574820797 · DOI
10.1111/j.1600-065X.1992.tb00624.x · DOI
10.1038/35037021 · DOI
10.1067/mai.2000.109428 · DOI
10.1038/nri914 · DOI
10.1016/S0952-7915(02)00396-5 · DOI
10.1016/j.coi.2003.09.010 · DOI
10.1016/j.it.2004.03.005 · DOI
Dvorak AM, 1972, Lab. Invest., 26, 27
Dvorak AM, 1992, Immunol. Ser., 57, 169
10.1182/blood.V83.12.3600.3600 · DOI
10.1016/S0165-2427(96)05696-6 · DOI
10.1016/S0952-7915(00)00154-0 · DOI
10.1084/jem.186.3.343 · DOI
Askenase PW, 1983, J. Immunol., 131, 2687, 10.4049/jimmunol.131.6.2687 · DOI
10.1084/jem.192.10.1441 · DOI
10.1016/S1074-7613(04)00080-9 · DOI
Thomas WR, 1983, J. Immunol., 130, 2565, 10.4049/jimmunol.130.6.2565 · DOI
10.1126/science.6494907 · DOI
Mekori YA, 1985, J. Immunol., 135, 879, 10.4049/jimmunol.135.2.879 · DOI
10.1084/jem.162.6.1935 · DOI
10.1159/000234031 · DOI
10.1084/jem.191.5.813 · DOI
10.1034/j.1600-065X.2000.917305.x · DOI
10.1172/JCI200111494 · DOI
10.1084/jem.194.1.F1 · DOI
10.1034/j.1600-065X.2001.790102.x · DOI
10.1038/35096564 · DOI
10.1038/nature01324 · DOI
10.1126/science.1073176 · DOI
10.1016/S1471-4906(03)00233-3 · DOI
10.1111/j.0906-6705.2003.0109a.x · DOI
10.1128/9781555817671.ch6 · DOI
10.1016/j.it.2004.02.013 · DOI
10.1016/j.jneuroim.2003.10.041 · DOI
10.1016/S0952-7915(99)80010-7 · DOI
10.4049/jimmunol.172.11.6768 · DOI
10.1074/jbc.M202575200 · DOI
10.1074/jbc.C200635200 · DOI
10.1038/ni0802-707 · DOI
10.1159/000063864 · DOI
10.1172/JCI200315719 · DOI
10.1042/BST0310286 · DOI
10.1182/blood-2003-07-2260 · DOI
10.1126/science.276.5311.418 · DOI
10.1084/jem.20040382 · DOI
10.1016/S0962-8924(00)01740-2 · DOI
10.1038/ni1093 · DOI
10.1016/S0165-2478(99)00024-3 · DOI
10.1016/S0952-7915(99)00027-8 · DOI
10.1016/S0952-7915(02)00400-4 · DOI
10.1002/immu.200390011 · DOI
10.1038/379346a0 · DOI
10.1038/nm0502-518 · DOI
10.1016/S0161-5890(02)00079-2 · DOI
10.1016/S0161-5890(02)00081-0 · DOI
10.1067/mai.2001.113562 · DOI
10.1084/jem.20020516 · DOI
10.1038/297229a0 · DOI
Leal-Berumen I, 1994, J. Immunol., 152, 5468, 10.4049/jimmunol.152.11.5468 · DOI
10.1073/pnas.95.19.11330 · DOI
10.1016/S0091-6749(99)70367-2 · DOI
10.1067/mai.2001.119159 · DOI
10.1016/0165-2478(96)02599-0 · DOI
10.1084/jem.185.4.663 · DOI
Lantz CS, 1997, J. Immunol., 158, 2517, 10.4049/jimmunol.158.6.2517 · DOI
Yamaguchi M, 1999, J. Immunol., 162, 5455, 10.4049/jimmunol.162.9.5455 · DOI
MacGlashan D, 2001, J. Leukoc. Biol., 70, 207, 10.1189/jlb.70.2.207 · DOI
10.4049/jimmunol.167.6.3427 · DOI
10.4049/jimmunol.167.3.1290 · DOI
10.1016/S0952-7915(02)00404-1 · DOI
10.1016/S1074-7613(01)00159-5 · DOI
10.1073/pnas.1735525100 · DOI
10.1084/jem.20012037 · DOI
10.1016/S1074-7613(01)00157-1 · DOI
10.1126/science.1079731 · DOI
Marquardt DL, 1978, J. Immunol., 120, 871, 10.4049/jimmunol.120.3.871 · DOI
Marquardt DL, 1986, Am. Rev. Respir. Dis, 113, 1105
10.1016/S1074-7613(02)00282-0 · DOI
10.1042/bst0310275 · DOI
10.1172/JCI8253 · DOI
10.1182/blood-2002-12-3929 · DOI
10.1084/jem.20032082 · DOI
10.1084/jem.20021806 · DOI
10.1007/BF02982122 · DOI
10.1182/blood.V52.2.447.447 · DOI · Paper page
10.1098/rspb.1982.0050 · DOI
10.1172/JCI200419062 · DOI
Grimbaldeston MA, 2005, FASEB J. (Abstr.)
10.1182/blood.V94.8.2658.420k23_2658_2666 · DOI
Duttlinger R, 1993, Development, 118, 705, 10.1242/dev.118.3.705 · DOI
10.1182/blood.V83.12.3509.3509 · DOI
10.1038/32190 · DOI
10.1084/jem.162.3.1025 · DOI · Paper page
10.1073/pnas.160254997 · DOI · Paper page
10.1053/gast.1996.v110.pm8613053 · DOI
10.1084/jem.165.3.615 · DOI
10.1172/JCI116277 · DOI
10.1084/jem.192.3.455 · DOI
10.4049/jimmunol.171.8.4385 · DOI
10.1016/S0002-9440(10)65634-9 · DOI
10.1016/S0002-9440(10)64125-9 · DOI
10.1046/j.1365-2249.1996.d01-610.x · DOI
10.1084/jem.20022157 · DOI
10.1084/jem.175.1.245 · DOI
10.1093/emboj/19.20.5387 · DOI
10.1038/nature03085 · DOI · Paper page
10.2307/3281760 · DOI
10.1182/blood.V69.6.1661.1661 · DOI
10.1182/blood.V75.8.1637.1637 · DOI
10.1084/jem.172.1.403 · DOI
10.1016/0020-7519(93)90159-V · DOI
10.1159/000236583 · DOI
Wershil BK, 1987, J. Immunol., 139, 2605, 10.4049/jimmunol.139.8.2605 · DOI
10.1172/JCI115016 · DOI
10.1172/JCI114025 · DOI
10.1172/JCI119255 · DOI
10.1172/JCI115344 · DOI
10.1084/jem.188.9.1587 · DOI
10.1084/jem.20022129 · DOI
10.1067/mai.2002.123302 · DOI
Latour S, 1992, J. Immunol., 149, 2155, 10.4049/jimmunol.149.6.2155 · DOI
10.4049/jimmunol.164.7.3855 · DOI
10.1165/ajrcmb.12.4.7695919 · DOI
10.1016/j.jaci.2004.12.762 · DOI
10.1046/j.1365-2222.2003.01588.x · DOI
10.4049/jimmunol.169.4.2044 · DOI
10.1038/nm722 · DOI
10.1164/ajrccm/141.5_Pt_1.1289 · DOI
10.1159/000235316 · DOI
10.1111/j.1365-2222.1994.tb00920.x · DOI
10.1084/jem.186.3.449 · DOI
10.1111/j.1365-3024.1985.tb00088.x · DOI · Paper page
10.1111/j.1365-3024.1987.tb00486.x · DOI
Matsuda H, 1990, J. Immunol., 144, 259, 10.4049/jimmunol.144.1.259 · DOI · Paper page
Wershil BK, 1994, J. Immunol., 152, 4563, 10.4049/jimmunol.152.9.4563 · DOI
10.4049/jimmunol.170.4.1630 · DOI
10.1016/0020-7519(91)90020-8 · DOI
Brown SJ, 1982, J. Immunol., 129, 790, 10.4049/jimmunol.129.2.790 · DOI · Paper page
10.1007/978-1-4684-5158-0_12 · DOI
10.1182/blood.V81.10.2572.2572 · DOI · Paper page
10.1182/blood.V86.5.1968.bloodjournal8651968 · DOI · Paper page
Friedman MM, 1987, Am. Rev. Respir. Dis., 135, 1157
10.1016/0167-5699(96)80580-9 · DOI
10.1111/1523-1747.ep12514713 · DOI
Razin E, 1984, J. Immunol., 132, 1479, 10.4049/jimmunol.132.3.1479 · DOI
Alam R, 1994, J. Immunol., 152, 1298, 10.4049/jimmunol.152.3.1298 · DOI
10.1172/JCI3704 · DOI
Frandji P, 1993, J. Immunol., 151, 6318, 10.4049/jimmunol.151.11.6318 · DOI
10.1006/cimm.1994.1272 · DOI
Malaviya R, 1994, J. Immunol., 152, 1907, 10.4049/jimmunol.152.4.1907 · DOI
Malaviya R, 1996, J. Immunol., 156, 1490, 10.4049/jimmunol.156.4.1490 · DOI
10.1016/S0167-5699(97)01034-7 · DOI
10.1016/S0923-1811(97)00033-9 · DOI
10.1002/(SICI)1521-4141(199803)28:03<844::AID-IMMU844>3.3.CO;2-W · DOI
10.1002/jlb.64.6.791 · DOI
Rumsaeng V, 1997, J. Immunol., 159, 2904, 10.4049/jimmunol.159.6.2904 · DOI
10.1038/ni971 · DOI
10.1073/pnas.88.10.4220 · DOI
10.1111/1523-1747.ep12326075 · DOI
10.1016/S0952-7915(02)00395-3 · DOI
Inamura N, 1998, J. Immunol., 160, 4026, 10.4049/jimmunol.160.8.4026 · DOI
10.1002/jlb.63.3.337 · DOI
10.4049/jimmunol.167.7.4008 · DOI · Paper page
10.1172/JCI200421087 · DOI
10.1016/S0167-5699(97)01186-9 · DOI
10.1084/jem.166.6.1654 · DOI
10.1111/j.1600-065X.1997.tb00956.x · DOI
10.1046/j.1365-2567.2001.01178.x · DOI
Ptak W, 1991, J. Immunol., 146, 3929, 10.4049/jimmunol.146.11.3929 · DOI
10.4049/jimmunol.173.8.5275 · DOI
10.1084/jem.187.12.2045 · DOI · Paper page
10.1038/335073a0 · DOI
10.1152/jappl.2001.91.3.1372 · DOI
10.1038/ni1005 · DOI
10.1038/ni1203-1160 · DOI
Eager KB, 1989, J. Immunol., 143, 2328, 10.4049/jimmunol.143.7.2328 · DOI
10.4049/jimmunol.167.7.3682 · DOI
10.1046/j.1523-1747.2001.01328.x · DOI
10.1046/j.1365-2567.2001.01187.x · DOI
10.1038/nm872 · DOI
10.1016/S0091-6749(99)70316-7 · DOI
10.1016/S0161-5890(02)00091-3 · DOI
10.1159/000235393 · DOI
10.1002/eji.200323830 · DOI
Li L, 1998, J. Immunol., 161, 5079, 10.4049/jimmunol.161.9.5079 · DOI

200 of 202 shown

Sorted by citations

Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947
The development of allergic inflammation
Galli, S. J., Tsai, M., & Piliponsky, A. M. (2008) · Nature · doi:10.1038/nature07204 · Cited by 1,839
Self-citation
IgE and mast cells in allergic disease
Galli, S. J., & Tsai, M. (2012) · Nature Medicine · doi:10.1038/nm.2755 · Cited by 1,799
Self-citation
Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils
Galli, S. J., Borregaard, N., & Wynn, T. A. (2011) · Nature Immunology · doi:10.1038/ni.2109 · Cited by 1,055
Self-citation
Mast cells are essential intermediaries in regulatory T-cell tolerance
Lu, L.-F., Lind, E. F., Gondek, D. C., Bennett, K. A., Gleeson, M. W., Pino-Lagos, K., Scott, Z. A., Coyle, A. J., Reed, J. L., Van Snick, J., et al. (2006) · Nature · doi:10.1038/nature05010 · Cited by 751
The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines
Austin, P. J., & Moalem-Taylor, G. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.013 · Cited by 607
Regulation of immunological homeostasis in the respiratory tract
Holt, P. G., Strickland, D. H., Wikström, M. E., & Jahnsen, F. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2236 · Cited by 528
Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity
Galli, S. J., & Tsai, M. (2010) · European Journal of Immunology · doi:10.1002/eji.201040559 · Cited by 403
Self-citation
Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum
Guilarte, M., Santos, J., de Torres, I., Alonso, C., Vicario, M., Ramos, L., Martinez, C., Casellas, F., Saperas, E., & Malagelada, J. R. (2007) · Gut · doi:10.1136/gut.2006.100594 · Cited by 385
Pathophysiology of allergic inflammation
Barnes, P. J. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01020.x · Cited by 361
Crosstalk between the circadian clock circuitry and the immune system
Cermakian, N., Lange, T., Golombek, D., Sarkar, D., Nakao, A., Shibata, S., & Mazzoccoli, G. (2013) · Chronobiology International · doi:10.3109/07420528.2013.782315 · Cited by 279
Microglia and mast cells: two tracks on the road to neuroinflammation
Skaper, S. D., Giusti, P., & Facci, L. (2012) · The FASEB Journal · doi:10.1096/fj.11-197194 · Cited by 235
Contribution of adipose tissue to development of cancer
Cozzo, A. J., Fuller, A. M., & Makowski, L. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170008 · Cited by 188
The Skin-Resident Immune Network
Tay, S. S., Roediger, B., Tong, P. L., Tikoo, S., & Weninger, W. (2014) · Current Dermatology Reports · doi:10.1007/s13671-013-0063-9 · Cited by 147
Dual biological effects of the cytokines interleukin-10 and interferon-γ
Wilke, C. M., Wei, S., Wang, L., Kryczek, I., Kao, J., & Zou, W. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1104-5 · Cited by 138
Mast cell activation and autism
Theoharides, T. C., Angelidou, A., Alysandratos, K.-D., Zhang, B., Asadi, S., Francis, K., Toniato, E., & Kalogeromitros, D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.017 · Cited by 125
Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management
Pardanani, A. (2023) · American Journal of Hematology · doi:10.1002/ajh.26962 · Cited by 132
Mast cells, versatile gatekeepers of pain
Chatterjea, D., & Martinov, T. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2014.03.001 · Cited by 110
Mast Cells in Allergic and Inflammatory Diseases
Sismanopoulos, N., Delivanis, D.-A., Alysandratos, K.-D., Angelidou, A., Therianou, A., Kalogeromitros, D., & C. Theoharides, T. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800165997 · Cited by 87
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
Gülen, T., Akin, C., Bonadonna, P., Siebenhaar, F., Broesby-Olsen, S., Brockow, K., Niedoszytko, M., Nedoszytko, B., Oude Elberink, H. N. G., Butterfield, J. H., et al. (2021) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2021.06.011 · Cited by 83
“INTRODUCTION Mast cells (MCs) are granulated, multifunctional effector cells of the immune system that are found in all vascularized tissues.(1-5) Upon stimulation, MCs secrete proinflammatory and vasoactive mediators.”
BackgroundMethod
Cellular recruitment and cytokine generation in a rat model of allergic lung inflammation are differentially modulated by progesterone and estradiol
de Oliveira, A. P. L., Domingos, H. V., Cavriani, G., Damazo, A. S., dos Santos Franco, A. L., Oliani, S. M., Oliveira-Filho, R. M., Vargaftig, B. B., & de Lima, W. T. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00286.2006 · Cited by 79
Mast cells and IgE in defense against venoms: Possible “good side” of allergy?
Galli, S. J., Starkl, P., Marichal, T., & Tsai, M. (2016) · Allergology International · doi:10.1016/j.alit.2015.09.002 · Cited by 73
Self-citation
Anaphylaxis: Mechanisms of Mast Cell Activation
Kalesnikoff, J., & Galli, S. J. (2010) · Chemical Immunology and Allergy · doi:10.1159/000315937 · Cited by 67
Self-citation
Prostaglandin D 2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives
Marone, G., Galdiero, M. R., Pecoraro, A., Pucino, V., Criscuolo, G., Triassi, M., & Varricchi, G. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1555237 · Cited by 62
Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects
Molderings, G. J., Meis, K., Kolck, U. W., Homann, J., & Frieling, T. (2010) · Immunogenetics · doi:10.1007/s00251-010-0474-8 · Cited by 58
Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy
Galli, S. J., Metz, M., Starkl, P., Marichal, T., & Tsai, M. (2020) · Allergo Journal International · doi:10.1007/s40629-020-00118-6 · Cited by 57
Self-citation
Anaphylaxis and Mast Cell Disorders
Gülen, T., & Akin, C. (2022) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2021.09.007 · Cited by 51
The modulatory effects of gut microbes and metabolites on blood-brain barrier integrity and brain function in sepsis-associated encephalopathy
Li, Z., Zhang, F., Sun, M., Liu, J., Zhao, L., Liu, S., Li, S., & Wang, B. (2023) · PeerJ · doi:10.7717/peerj.15122 · Cited by 43
“The SAE model was established by cecal ligation and puncture (CLP) as previously described ( Galli et al., 2005 ) with slight modifications.”
Meningeal mast cells as key effectors of stroke pathology.
Arac, A., Grimbaldeston, M. A., Galli, S. J., Bliss, T. M., & Steinberg, G. K. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00126 · Cited by 37
Self-citation
Progesterone reduces the migration of mast cells toward the chemokine stromal cell-derived factor-1/CXCL12 with an accompanying decrease in CXCR4 receptors.
Belot, M.-P., Abdennebi-Najar, L., Gaudin, F., Lieberherr, M., Godot, V., Taïeb, J., Emilie, D., & Machelon, V. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00286.2006 · Cited by 29
Involvement of peripheral mast cells in a fibromyalgia model in mice
Brum, E. D. S., Fialho, M. F. P., Becker, G., Nogueira, C. W., & Oliveira, S. M. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176385 · Cited by 11

Authors: Galli, S. J., Kalesnikoff, J., Grimbaldeston, M. A., Piliponsky, A. M., Williams, C. M. M., & Tsai, M.
Venue: Annual Review of Immunology
Publisher: Annual Reviews
Published: 2005-04-01
Volume: 23
Issue: 1
Pages: 749-786
ISSN: 0732-0582
1545-3278
DOI: 10.1146/annurev.immunol.21.120601.141025
Cited by: 1,017
References: 3
Language: en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

MAST CELLS AS “TUNABLE” EFFECTOR AND IMMUNOREGULATORY CELLS: Recent Advances

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Metadata

Record

About these checks